Genta initiates trials with Genasense.
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D013873:Thionucleotides / Q000627:therapeutic use*
D016376:Oligonucleotides, Antisense; D013873:Thionucleotides; C408162:oblimersen